Literature DB >> 8851498

Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte.

D Lagadic-Gossmann1, K Le Prigent, D Feuvray.   

Abstract

1. We have examined the effects of trimetazidine (TMZ) on intracellular pH (pHi) regulation in rat isolated ventricular myocytes. pHi was recorded ratiometrically by use of the pH-sensitive fluoroprobe, carboxy-SNARF-1 (carboxy-seminaphtorhodafluor). 2. Following an intracellular acid load (induced by 10 mM NH4Cl removal), pHi recovery in HEPES-buffered Tyrode solution was significantly slowed down upon application of 0.3 mM TMZ only when myocytes were pretreated for 5 h 30 min (slowing by approximately 50%; P < 0.01). This effect of TMZ on pHi recovery was shown to be not only time- but also dose-dependent with a large, quickly reversible, effect obtained with 1 mM TMZ applied for 2-3 h (slowing by approximately 64%; P < 0.001). This slowing of pHi recovery was also associated with a decrease of the NH4+ removal-induced acidification. 3. Relationship between intracellular intrinsic buffering power (beta i) and pHi was assessed in absence or presence of TMZ (0.3 mM or 1 mM). As expected, beta i increased roughly linearly with a decrease in pHi in all cases. However, both concentrations of TMZ significantly increased beta i (by approximately 55 and 65% at pHi 7.1, respectively). 4. When Na+/H+ exchange was inhibited by dimethyl amiloride (DMA; 40 microM), trimetazidine (1 mM) did not change the H+ flux estimated at pHi 7.1 (0.31 +/- 0.03 mequiv l-1 min-1, n = 5, control, versus 0.30 +/- 0.025 mequiv l-1 min-1, n = 5, TMZ), ruling out any effect of TMZ on background acid loading. 5. Acid efflux carried by Na+/H+ exchange was significantly decreased only when myocytes were pretreated with 1 mM TMZ, for 2-3 h (JeH = 2.86 +/- 0.38 mequiv l-1 min-1, n = 26, control, versus 1.66 +/- 0.26 mequiv l-1 min-1, n = 10, TMZ, estimated at pHi 7.1; P < 0.05). 6. In conclusion, the present work demonstrates that, following an intracellular acid load in HEPES-buffered medium, trimetazidine slows down pHi recovery in rat isolated ventricular myocytes, primarily through an increase of beta i. An effect on Na+/H+ exchange is also detected but only after long-term incubation of the myocytes with TMZ.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8851498      PMCID: PMC1909418          DOI: 10.1111/j.1476-5381.1996.tb15268.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Modulation of rat distal colonic brush-border membrane Na+-H+ exchange by dexamethasone: role of lipid fluidity.

Authors:  P K Dudeja; E S Foster; T A Brasitus
Journal:  Biochim Biophys Acta       Date:  1987-12-11

Review 2.  Mechanisms of Ca2+ overload in reperfused ischemic myocardium.

Authors:  M Tani
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

3.  Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ.

Authors:  J A Thomas; R N Buchsbaum; A Zimniak; E Racker
Journal:  Biochemistry       Date:  1979-05-29       Impact factor: 3.162

Review 4.  Intracellular pH.

Authors:  A Roos; W F Boron
Journal:  Physiol Rev       Date:  1981-04       Impact factor: 37.312

5.  pH dependence of intrinsic H+ buffering power in the sheep cardiac Purkinje fibre.

Authors:  R D Vaughan-Jones; M L Wu
Journal:  J Physiol       Date:  1990-06       Impact factor: 5.182

6.  Acidification and intracellular sodium ion activity during stimulated myocardial ischemia.

Authors:  B Vanheel; A de Hemptinne; I Leusen
Journal:  Am J Physiol       Date:  1990-07

7.  Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart.

Authors:  N Lavanchy; J Martin; A Rossi
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-03

8.  Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts.

Authors:  J R Neely; L W Grotyohann
Journal:  Circ Res       Date:  1984-12       Impact factor: 17.367

9.  Intracellular pH transients in squid giant axons caused by CO2, NH3, and metabolic inhibitors.

Authors:  W F Boron; P De Weer
Journal:  J Gen Physiol       Date:  1976-01       Impact factor: 4.086

10.  22Na+ fluxes in thymic lymphocytes. II. Amiloride-sensitive Na+/H+ exchange pathway; reversibility of transport and asymmetry of the modifier site.

Authors:  S Grinstein; J D Goetz; A Rothstein
Journal:  J Gen Physiol       Date:  1984-10       Impact factor: 4.086

View more
  6 in total

1.  The pH-partition profile of the anti-ischemic drug trimetazidine may explain its reduction of intracellular acidosis.

Authors:  F Reymond; G Steyaert; P A Carrupt; D Morin; J P Tillement; H H Girault; B Testa
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

Review 2.  Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.

Authors:  K J McClellan; G L Plosker
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

3.  Trimetazidine increases phospholipid turnover in ventricular myocyte.

Authors:  E Sentex; J P Sergiel; A Lucien; A Grynberg
Journal:  Mol Cell Biochem       Date:  1997-10       Impact factor: 3.396

4.  Ionic and metabolic imbalance in various conditions of ischemia-reperfusion: a 31P- and 23Na-NMR study.

Authors:  M Bernard; H el Banani; P J Cozzone; D Feuvray
Journal:  MAGMA       Date:  1998-09       Impact factor: 2.310

5.  Effects of sustained-release trimetazidine on chronically dysfunctional myocardium of ischemic dilated cardiomyopathy - Six months follow-up result.

Authors:  A Momen; M Ali; P K Karmakar; M Z Ali; A Haque; M R Khan; M I Khalil; M S Hossain; R M Huda; M N Goni
Journal:  Indian Heart J       Date:  2016-04-13

6.  Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine.

Authors:  Suman Jatain; Aditya Kapoor; Archana Sinha; Roopali Khanna; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Pravin Goel
Journal:  Indian Heart J       Date:  2016-05-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.